Joshi A, Bhaskar N, Pearson J
Cancers (Basel). 2025; 17(2).
PMID: 39858043
PMC: 11763869.
DOI: 10.3390/cancers17020260.
Cai S, Yang W, Luo H, Li Z, Huang X, Li J
PLoS One. 2024; 19(11):e0313221.
PMID: 39514581
PMC: 11548789.
DOI: 10.1371/journal.pone.0313221.
Liu J, Cao Y, Shao T, Wang Y
Heliyon. 2024; 10(12):e32907.
PMID: 39015806
PMC: 11250850.
DOI: 10.1016/j.heliyon.2024.e32907.
Zhang Y, Hao Y, Pan H, Zheng H, Zhou J
J Thorac Dis. 2024; 15(12):7013-7023.
PMID: 38249933
PMC: 10797352.
DOI: 10.21037/jtd-23-1772.
Zullo L, DallOlio F, Rossi G, Dellepiane C, Barletta G, Bennicelli E
Int J Mol Sci. 2024; 25(1).
PMID: 38203395
PMC: 10779291.
DOI: 10.3390/ijms25010224.
A rare epidermal growth factor receptor (EGFR) gene mutation in small cell lung carcinoma patients.
Hwang C, Hsieh T, Yeh K, Chen T, Hua C, Chang L
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2022; 166(3):274-279.
PMID: 35228756
DOI: 10.5507/bp.2022.007.
Molecular genetic profiling of small cell lung carcinoma in a Chinese cohort.
Wang Z, Jiang Z, Lu H
Transl Cancer Res. 2022; 8(1):255-261.
PMID: 35116754
PMC: 8798498.
DOI: 10.21037/tcr.2019.01.26.
A Rare Case of Small Cell Lung Cancer With an Epidermal Growth Factor Receptor Mutation and Its Response to Osimertinib.
Bhuiyan S, Siddiqui R, Zirkiyeva M, Agladze M, Bashir T
Cureus. 2021; 13(5):e15136.
PMID: 34164239
PMC: 8214366.
DOI: 10.7759/cureus.15136.
Extensive-Stage Small Cell Carcinoma Transformation From EGFR Del19-Mutant Lung Adenocarcinoma on Gefitinib at the Twelfth-Year Follow-Up Case Report.
Kok V, Lee C, Chiang Y, Wang M, Lu Y, Cherng C
Front Oncol. 2021; 11:564799.
PMID: 33816221
PMC: 8012892.
DOI: 10.3389/fonc.2021.564799.
Resistance to Both Chemotherapy and EGFR-TKI in Small Cell Lung Cancer With EGFR 19-Del Mutation: A Case Report.
Wang L, Dong F, Su J, Du G, Shao Y, Liu Y
Front Oncol. 2020; 10:1048.
PMID: 32766137
PMC: 7379871.
DOI: 10.3389/fonc.2020.01048.
Primary tumor standardized uptake value (SUVmax) measured on F-FDG PET/CT and mixed NSCLC components predict survival in surgical-resected combined small-cell lung cancer.
Hui Z, Wei F, Ren H, Xu W, Ren X
J Cancer Res Clin Oncol. 2020; 146(10):2595-2605.
PMID: 32494919
PMC: 7467962.
DOI: 10.1007/s00432-020-03240-8.
Pathological transition as the arising mechanism for drug resistance in lung cancer.
Chen Y, Tang W, Tong X, Ji H
Cancer Commun (Lond). 2019; 39(1):53.
PMID: 31570104
PMC: 6771104.
DOI: 10.1186/s40880-019-0402-8.
Multigene Mutation Profiling and Clinical Characteristics of Small-Cell Lung Cancer in Never-Smokers vs. Heavy Smokers (Geno1.3-CLICaP).
Cardona A, Rojas L, Zatarain-Barron Z, Ruiz-Patino A, Ricaurte L, Corrales L
Front Oncol. 2019; 9:254.
PMID: 31058075
PMC: 6481272.
DOI: 10.3389/fonc.2019.00254.
Overcoming T790M mutant small cell lung cancer with the third-generation EGFR-TKI osimertinib.
Tang K, Jiang N, Kuang Y, He Q, Li S, Luo J
Thorac Cancer. 2018; 10(2):359-364.
PMID: 30521113
PMC: 6360229.
DOI: 10.1111/1759-7714.12927.
A combined subtype of small cell lung cancer and adenocarcinoma with epidermal growth factor receptor () mutation responds to EGFR tyrosine kinase inhibitors.
Zhang Y, Ye L, Zhang H, Chen X, Ji H, Chen G
J Thorac Dis. 2018; 10(10):E739-E743.
PMID: 30505514
PMC: 6236185.
DOI: 10.21037/jtd.2018.09.101.
Combined small-cell lung carcinoma.
Qin J, Lu H
Onco Targets Ther. 2018; 11:3505-3511.
PMID: 29950855
PMC: 6016273.
DOI: 10.2147/OTT.S159057.
, , , , and mutation in plasma of small cell lung cancer patients.
Lu H, Qin J, Han N, Lei L, Xie F, Li C
Onco Targets Ther. 2018; 11:2217-2226.
PMID: 29720878
PMC: 5916454.
DOI: 10.2147/OTT.S159612.
Transformation to small-cell lung cancer following treatment with icotinib in a patient with lung adenocarcinoma.
Lu H, Chen B, Qin J, Xie F, Han N, Huang Z
Oncol Lett. 2018; 15(4):5799-5802.
PMID: 29552210
PMC: 5840615.
DOI: 10.3892/ol.2018.8040.
24-Methyl-Cholesta-5,24(28)-Diene-3β,19-diol-7β-Monoacetate Inhibits Human Small Cell Lung Cancer Growth In Vitro and In Vivo via Apoptosis Induction.
Chung T, Su J, Lin C, Li Y, Chao Y, Lin S
Mar Drugs. 2017; 15(7).
PMID: 28671570
PMC: 5532652.
DOI: 10.3390/md15070210.
Biopsy and re-biopsy in lung cancer: the oncologist requests and the role of endobronchial ultrasounds transbronchial needle aspiration.
Tuzi A, Bolzacchini E, Suter M, Giaquinto A, Passaro A, Gobba S
J Thorac Dis. 2017; 9(Suppl 5):S405-S409.
PMID: 28603652
PMC: 5459872.
DOI: 10.21037/jtd.2017.04.09.
